Back to mobile site

Intra-Cellular Therapies (ITCI) PT More Than Doubled at Cowen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

August 6, 2015 8:14 AM EDT
Get Alerts ITCI Hot Sheet
Price: $131.87 --0%

Rating Summary:
    9 Buy, 11 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 14 | New: 26
Join SI Premium – FREE

Cowen analyst Ritu Baral sharply raised the price target on Outperform-rated Intra-Cellular Therapies (NASDAQ: ITCI) to $62.00 (from $29.00) ahead of the '007 Ph3 read-out.

The firm has increased conviction around the clinical success of the program. "We look forward for the first Ph3 read-out in Sept/Oct and Ph 2 schizophrenic patient PET data in close proximity," Baral said.

For an analyst ratings summary and ratings history on Intra-Cellular Therapies click here. For more ratings news on Intra-Cellular Therapies click here.

Shares of Intra-Cellular Therapies closed at $29.00 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst PT Change, FDA, Hot Comments

Related Entities

The Children's Investment Fund (TCI), Cowen & Co